Now, let’s get to the juicy part. In a dataset that goes back to January 2019, the 4-6-U sequence has flashed 13 times on a ...

Q2 earnings are scheduled to be released on August 7, after market close. The pharma company is expected to post an EPS of $1 ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s ...

Analysts expect Gilead Sciences to report an earnings per share (EPS) of $1.95. Investors in Gilead Sciences are eagerly ...

The stock's fall snapped a two-day winning streak.

This was the stock's second consecutive day of gains.

The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.

On Monday, Gilead Sciences GILD got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96. Looking For Winning ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black women-serving organizations in the U.S. since 2010, with $28 million granted to ...

Washington has long failed to come up with a solution for rising drug prices that addresses the concerns of drugmakers, ...